Clinical Trials Sponsored by Viollier Inc.

Total 35538 results

Ocular Therapeutix, Inc.
ORA, Inc.

Completed

OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye

Dry Eye
Woodmont Pharmaceuticals, Inc.
ORA, Inc.

Terminated

Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections

Allergic Rhinitis | Allergic Conjunctivitis

United States
Eisai Inc.
H3 Biomedicine Inc.

Completed

A Study to Evaluate the Food-Effect of H3B-6527

Healthy Participants

United States
Momenta Pharmaceuticals, Inc.
Mylan Inc.

Completed

Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects

Healthy Volunteers

United Kingdom
Seagen Inc.
Millennium Pharmaceuticals, Inc.

Completed

A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms

Lymphoma, Large-Cell, Anaplastic | Lymphoma, NK-cell | Lymphoma, T-cell

United States, United Kingdom
ImmunoVaccine Technologies, Inc. (IMV Inc.)

Completed

Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

United States, Canada
Seagen Inc.
Millennium Pharmaceuticals, Inc.

Completed

A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma

Lymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic

United States, France, Canada, Belgium, United Kingdom
Eisai Korea Inc.

Completed

A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS) (ADOS)

Alzheimer's Disease

China, Taiwan, Korea, Republic of, Singapore, Thailand, Philippines
Deacon Biosciences, Inc.
ORA, Inc.

Completed

A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers

Ocular Infection

United States
Kinex Pharmaceuticals Inc.

Completed

Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)

Acute Myelogenous Leukemia

United States
FORUM Pharmaceuticals Inc
Quintiles, Inc.

Withdrawn

Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine

Dementia | Alzheimer's Disease | Cognition

United States
Seagen Inc.
Millennium Pharmaceuticals, Inc.

Completed

Cardiac Safety Study of Brentuximab Vedotin (SGN-35)

Lymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, Hodgkin

United States, Germany
Mati Therapeutics Inc.
QLT Inc.

Completed

A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG

Ocular Hypertension | Open-Angle Glaucoma

United States
Eisai China Inc.

Completed

Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar DDD in China

Lumbar Disc Degenerative Disease

China
Eisai Korea Inc.

Completed

A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

Epilepsy

Korea, Republic of
Verrica Pharmaceuticals Inc.
Paidion Research, Inc.; Instat Consulting, Inc.; Database Integrations, Inc.

Completed

Cantharidin Application in Molluscum Patients-1 (CAMP-1)

Molluscum Contagiosum

United States
MedRhythms, Inc.
Alexion Pharmaceuticals, Inc.

Not yet recruiting

Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder (aNiMatO)

Neuromyelitis Optica Spectrum Disorder

United States
Technoderma Medicines Inc.
Therapeutics, Inc.

Recruiting

Study of TDM-180935 in Atopic Dermatitis Patients

Atopic Dermatitis

United States
Lyssn.io, Inc.
ProtoCall Services, Inc.

Not yet recruiting

The Use of Voice-Based AI in 988 Crisis Counseling

Suicide | Suicide and Self-harm
Sirtsei Pharmaceuticals, Inc.
Rho, Inc.

Recruiting

A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

Major Depressive Disorder

United States
Lucid Diagnostics, Inc.

Recruiting

Lucid Registry Study (Lucid Registry)

Barrett Esophagus | Esophageal Adenocarcinoma | Barrett's Esophagus Without Dysplasia | Barretts Esophagus With Dysplasia

United States
Ceragem Clinical Inc.

Recruiting

CETIS-I (CEra Traction Improves Spine-I)

Lumbar Disc Herniation | Degenerative Spinal Stenosis | Spine Traction

Korea, Republic of
Ceragem Clinical Inc.

Recruiting

CEFID-II (CEra Flow Improves DVT-II)

Deep Vein Thrombosis | Blood Circulation Disorder

Korea, Republic of
HBI Solutions Inc.
mProbe Inc.

Not yet recruiting

Maternal Serum Markers Predicting Preeclampsia at Early Gestations

Preeclampsia
SerenaGroup, Inc.
Dabir Surfaces Inc

Recruiting

A Multicentre Prospective Study Evaluating an Off-loading Mattress Overlay System in Healing of Stage 3 Pressure Ulcers (DABIRPrU)

Pressure Ulcer

United States
NeuroActiva, Inc.
Biomed Industries, Inc.

Recruiting

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection (NATADEX)

Coronavirus Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Severe Acute Respiratory Infection

United States
AVM Biotechnology Inc
Medpace, Inc.

Recruiting

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies (OPAL)

Lymphoid Malignancies

United States
Lucid Diagnostics, Inc.

Recruiting

Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC (ESOGUARDBE2)

Barrett Esophagus | Esophageal Adenocarcinoma | Barrett's Esophagus Without Dysplasia | Barretts Esophagus With Dysplasia

United States, Netherlands
Mylan Pharmaceuticals Inc

Completed

Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets

Healthy

Canada
Mylan Pharmaceuticals Inc

Completed

Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg to Verelan® PM Extended-Release Capsules 300 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Levothyroxine Sodium Tablets 300 mcg to Synthroid® Tablets 300 mcg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Oxybutynin Chloride Extended-Release Tablets 15 mg and Ditropan XL® Tablets 15 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mg

Healthy

Canada
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting BE Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg

Healthy

United States

Clinical Trials Sponsored by Viollier Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations